Chicago ... it still befuddles me that we seem to be doing nothing with Asia/China given their dire issues with Covid, and their perceived need for a number of ABL potential benefits.

Just seems like an easy opportunity, with some prominent Asian connections on the BoD. I know it is not just that easy, and there may be some political blow back working with China specifically, in these political times. But, that area would just seem to have immense opportunity on an accelerated basis, for such a struggling company holding impressive "on target" but unproven credentials, and with Asian connections.

And I thought we were praparing to sell India around 6 million ABL pills last year? Can't even remember what happened with that? Were we hoping the "stopped" Covid P2 was so impressive, that we get EUA? Would India even care about that, given the bath tub brews that come out of that area? Seems like that is another country that we could possibly "bum rush" for business.

I'm not nearly educated enough on either of these scenarios though, so I may just be whining without cause or foundation?? 

Who knows?!